Encainide: A new and potent antiarrhythmic

This publication has 52 references indexed in Scilit:

• A Classification of Antiarrhythmic Actions Reassessed After a Decade of New Drugs
  The Journal of Clinical Pharmacology, 1984
• Clinical efficacy and electrophysiologic effects of encainide in patients with Wolff-Parkinson-White syndrome.
  Circulation, 1984
• Encainide for refractory ventricular tachyarrhythmia
  The American Journal of Cardiology, 1983
• Electrophysiologic actions of O-demethyl encainide: an active metabolite.
  Circulation, 1983
• Voltage- and time-dependent depression of maximum rate of depolarisation of guinea-pig ventricular action potentials by two new antiarrhythmic drugs, flecainide and lorcainide
  Cardiovascular Research, 1983
• Treatment of frequent ventricular arrhythmia with encainide: assessment using serial ambulatory electrocardiograms, intracardiac electrophysiologic studies, treadmill exercise tests, and radionuclide cineangiographic studies.
  Circulation, 1982
• Drug conversion of nonsustained ventricular tachycardia to sustained ventricular tachycardia during serial electrophysiologic studies: Identification of drugs that exacerbate tachycardia and potential mechanisms
  American Heart Journal, 1982
• Malignant ventricular tachyarrhythmias associated with the use of encainide
  American Heart Journal, 1981
• Antiarrhythmic efficacy of encainide in patients with refractory recurrent ventricular tachycardia.
  Circulation, 1981
• Total Suppression of Ventricular Arrhythmias by Encainide
  New England Journal of Medicine, 1980